Noninvasive Prenatal Testing (NIPT) Sequenom
Sequenom noninvasive prenatal testing (NIPT) is a chromosome counting method that analyzes genetic information in fetal cell-free DNA in maternal blood to determine risk for specific fetal chromosomal and subchromosomal abnormalities.
We offer three noninvasive prenatal testing through Sequenom: MaterniT21 PLUS, which screen for chromosomal abnormalities such as trisomies 21, 18, and 13 and several microdeletion syndromes; MaterniT GENOME, a genome-wide NIPT; and VisibiliT, which screens for trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome).
Whole blood: Two 10 mL BCT Streck tubes
- Ship at room temperature
- 7-10 days